1 Dringen R.Metabolism and functions of glutathione in brain[J].Prog Neurobiol,2000;62:649-71
2Paolicchi A,Dominici S,Pieril,et al.Glutathione catabolism as a signaling mechanism[J].BiochemPharmacol,2002;64:1027-35
3 Gilgun-sherki Y,Melamed E,Offen D,et al.Oxidative stress induced-neurodegenerative diseases:the need for antioxidants thatPenetrate the blood brain barrier[J].Neuropharmacology,2001;40:959-75
4 Sian J,Dexter DT,Lees AJ,et al.Alteration in glutathionelevels inParkinson' s disease and other neurodegenerative disorders affecting basal ganglia[J].Ann Neurol,1994a;36:348-55
5 Schulz JB,Lindenau J,Seyfried J,et al.Glutathione oxidative stress and neurodegeneration[J].Eur J Biochem,2000;267:4904-11
6 邱瑜,陈红专,金正均.谷氨酸神经细胞毒作用的新途径-谷氨酸胱氨酸转运体介导机制[J].中国药理学通报,2000;16:251-4
7 Jha N,Jurma O,Lalli G,et al.Glutathione depletion inPC12 results in selective inhibition of mitochondrial complexⅠ activity[J].J Bio Chem,2000;275:26096-101
8lee JC,Straffon M,Jang TY,et al.The essential and ancillary role of glutathione in Saccharomyces cerevisiae analysed using a grande gsh1 disruptant strain[J].FEMS Yeast Res,2001;1:57-65
9 Hirrlinger J,Schulz JB,Dringen R.Effects of dopamine on the glutathione metabolism of cultured astroglial cells;implications forParkinson' s disease[J].J Neurochem,2002;82:458-67
10 Dringen R,Gutterer JM,Hirrlinger J.Glutathione metabolism in brain:metabolic interaction between astrocytes and neurons in the defence against reactive oxygen species[J].Eur J Biochem,2000;267:4912-6
11 Mytilineou C,KoKotos-Leonardi ET,Kramer BC,et al.Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures[J].J Neurochem,1999;73:112-9
12 Mytilineou C,Kramer BC,Yabut JA.Glutathione depletion and oxidative stress[J].Parkinsonism Relat Disord,2002;8:385-7
13 Jha N,Kumar JM,Boonplueang R,et al.Glutathione decreases in dopaminergicPC12 cells interfere with the ubiquitinProtein degradationPathway:relevance forParkinson' s disease[J] ? J Neurochem,2002;80:555-61
14 Nagatsu T.Parkinson' s disease:changes in apoptosis-related factors suggestingPossible gene therapy[J].J Neural Transm,2002;109:731-45
15 Shimizu E,Hashimoto K,Komatsu N,et al.Roles of endogenous glutathionelevels on 6-hydroxydopamine-induced apoptotic neuronal cell death in human neuroblastoma SK-N-SH cells[J].Neuropharmacology,2002;43:434-43
16 Wǜllner U,Seyfried J,GroscurthP,et al.Glutathione depletion and neuronal cell death:the role of reactive oxygen intermediates and mitochondrial function[J].Brain Res,1999;826:53-62
17 KorotchkinalG,Yang H,Tirosh O,et al.Protection by thiols of the mitochondrial complexes from 4-hydroxy-2-nonenal[J].Free Radic Biol Med,2001;30:992-9
18 Xie C,Lovell MA,Xiong S,et al.Expression of glutathione-Stransferase isozyme in the SY5Y neuroblastoma cellline increases resistance to oxidative stress[J].Free Radic Biol Med,2001;31:73-81
19 Andersen JK.Do alterations in glutathione and ironlevels contribute toPathology associated withParkinson' s disease[J] ?Novartis Found Symp,2001;235:11-20
20 Bharath S,Hsu M,Kaur D,et al.Glutathione,iron andParkinson's disease[J].BiochemPharmacol,2002;64:1037-48
21 Tanaka K,Yoshioka M,Miy azaki I,et al.GPI1046Prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum[J].Neuroscilett,2002;321:45-8
22 Tanaka K,Miyazaki I,Fujita N,et al.Molecular mechanism in activation of glutathione system by ropinirole,a selective dopamine D2 agonist[J].Neurochem Res,2001;26:31-6 |
